PLENARY
LECTURES Angiogenesis: Principles and Importance in Cancer and Ischemic Heart Disease Ballroom Chairs: Jeffrey L. Evelhoch, Roderic I. Pettigrew and Robert M . Weisskoff |
Educational
Objectives Upon completion of this session participants should be able to: • Explain the basic principles of angiogenesis and its importance in cancer and ischemic heart disease. • Describe the principles of anti-angiogenic therapy and its potential clinical utility in oncology. • Explain the basis underlying MR methods used to assess the extent of angiogenesis in vivo. • List examples of information which MR studies of tumors in vivo can provide regarding the angiogenic process. • Describe the principles of angiogenic gene therapy and its potential clinical utility in ischemic heart disease. |
08:15 139. Angiogenesis: Fundamental and Medical Applications, Judah Folkman, Harvard University Medical School, Boston, MA, USA. |
08:40 140. MR Evaluation of Angiogenesis in Oncology, Michal Neeman, Weizmann Institute of Science, Rehovot, Israel. |
09:05 141. Angiogenic Therapy in Ischemic Heart Disease, Stephen E. Epstein, Cardiovascular Research Foundation at Washington Hospital Center, Washington, D.C., USA. |